Subscription Services may include provider review of your intake information, consultations (live or asynchronous), ongoing clinical support, andif prescribedcoordination of prescription fulfillment through partner pharmacies.
91 Llewellyn-SmithI
GLP-1 medications, known for helping with weight loss, offer surprising benefits for people with kidney disease
Semaglutide is generally discussed as a GLP-1 receptor agonist model, Tirzepatide as a dual GIP and GLP-1 receptor agonist model, and Retatrutide as a triple receptor agonist model involving GLP-1, GIP, and glucagon receptor pathways
SURMOUNT OSA demonstrated after 52 weeks of treatment, participants who received tirzepatide had greater likelihood of remission or improvement to mild OSA as well as reduced apnea-hypopnea index (AHI) values, hypoxic burden, and systolic blood pressure
Can semaglutide cause muscle loss, and how do I protect my muscles